CG
CLVS

Carmignac Gestion’s Clovis Oncology, Inc. CLVS Stock Holding History

Carmignac Gestion’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,514,940
Closed -$44.5M – 93
2018
Q3 		$44.5M Sell
1,514,940
-6,500
-0.4% -$252K 0.38% 44
2018
Q2 		$69.2M Buy
1,521,440
+11,900
+0.8% +$579K 0.52% 45
2018
Q1 		$79.7M Buy
1,509,540
+188,676
+14% +$11M 0.56% 44
2017
Q4 		$89.8M Buy
+1,320,864
New +$92.3M 0.6% 40

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $718M AUM 8.19% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SC
Samlyn Capital New York $5.82B AUM 36.3% 1-Year Est. Return